05 April 2012 Keywords: Roche Hercptin injectable Breast cancer Ph III Line extensionInjectable Herceptin set to transform breast cancer care says Roche Article | 25 March 2012 Data from the Phase III HannaH trial presented last Friday at the European Breast Cancer Conference Vienna Austria co ...

guest published in:04-05   reply:0   view:6    last updated:04-05 08:29( guest )

basel 20 April 2011 FDA Approves Roche s HPV Test for Identifying Women at Highest Risk for Cervical Cancer Roche (SIX: RO ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved the cobas HPV (Human Papillomavirus) Test which identifies women at highest ...

guest published in:05-21   reply:0   view:36    last updated:05-21 23:30( guest )

Our mission is to promote safe affordable necessary and efficient vaccines and vaccination practices through education and information. We believe in science-based medicine. Our primary goal is to provide the information necessary for you make informed decisions regarding your health and well- ...

guest published in:04-30   reply:0   view:35    last updated:04-30 00:29( guest )

author:admin    comment:0   view:11   userful 1

NEW YORK (GenomeWeb News) Qiagen and Roche today welcomed new guidelines recommending the use of molecular testing for human papillomavirus screening in conjunction with Pap smears.

author:admin    comment:0   view:13   userful 1

Full-text access for registered users only. Existing users login here . New to GenomeWeb? Register quickly here for free access. The Woyke lab is currently focused on gaining genomic insights into highly novel and under-explored taxa in the environment most of which are as yet uncultured.

author:admin    comment:0   view:12   userful 1

Roche Gets FDA Clearance For Test To Diagnose Chlamydia And Gonorrhea Infection

author:admin    comment:0   view:12   userful 1

Roche announced today that the U.S. Food and Drug Administration (FDA) has provided 510(k) clearance to the cobas CT/NG Test for the detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections in both symptomatic and asymptomatic patients from male urine and self -collecte ...

author:admin    comment:0   view:11   userful 1

PLEASANTON Calif. Feb. 1 2012 /PRNewswire/ -- Roche (SIX: RO ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has provided 510(k) clearance to the cobas CT/NG ...